Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ipsen Bioscience Inc.

Division of Ipsen Biopharmaceuticals Inc.

Latest From Ipsen Bioscience Inc.

Theravance Pushes On With Gastroparesis Candidate Amid Mixed Data

Theravance is working out what to do next with its investigational drug for gastroparesis after it produced mixed data in a Phase IIb trial in this underserved indication.

Clinical Trials Companies

Oncology Captures One In Three New EU Drug Approvals In 2016

2016 saw 30 new active substances approved in the EU, in a total of 29 different products, of which 10 were for cancer indications. Also approved were a range of combinations of old and new drugs, some new uses, and a number of biosimilars and generics. 14 of the products approved during the year were for rare diseases, while eight received a conditional marketing authorization.

Approvals BioPharmaceutical

Shedding Earlier Fears, Pharma Takes A Fresh Look At Cell, Gene Therapies

The early successes enjoyed by new autologous, cell-based cancer therapies, as well as new advances in gene therapy and regenerative medicine, have reignited interest at Big Pharma in these advanced treatments, said partnering executives at the recent Therapeutic Area Partnerships meeting in Boston.

BioPharmaceutical Deals

Ipsen Moves Aggressively On U.S. Strategy, Builds Out Commercial and R&D Infrastructure

As part of an ongoing strategic reorganization, Ipsen announced the appointment of a nine-member U.S. leadership team to execute on the growth of its neurology and endocrinology franchises.

North America Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Biomeasure Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ipsen Biopharmaceuticals Inc.
  • Senior Management
  • Robbin Eynon, CFO
    Jacques P Moreau, Pres.
    Sylviane Moreau, PhD, COO
  • Contact Info
  • Ipsen Bioscience Inc.
    Phone: (617) 679-8500
    650 East Kendall St.
    Cambridge, MA 02142